Evidence map›Paper›PMID 41785862›Full record

ReviewAmerican journal of human genetics2026

Incorporating polygenic risk scores and social determinants of health across populations: Considerations and best practices in research.

Sara J Cromer, Ewan K Cobran, Hari S Iyer, Micah R Hysong, Luciana B Vargas, Johanna L Smith, Iain R Konigsberg, David Bogumil, LáShauntá Glover, Gillian King and 6 more

Abstract readReview
In one paragraph

Review in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Breast cancer polygenic risk score performance varies by socioeconomic status.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Polygenic risk score translation across diverse populations.Frontiers in cardiovascular medicine · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sara J CromerDiabetes Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: scromer@mgh.harvard.edu.
Ewan K CobranDepartment of Quantitative Health Services, Mayo Clinic College of Medicine and Sciences, Scottsdale, AZ, USA.
Hari S IyerSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, NJ, USA.
Micah R HysongDepartment of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Luciana B VargasDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Johanna L SmithCardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Iain R KonigsbergDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
David BogumilDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, CA, USA.
LáShauntá GloverDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Gillian KingDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, CA, USA.
Polygenic Risk Methods Development (PRIMED) Consortium SDoH Working Group
Leslie A LangeDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Department of Epidemiology, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Aniruddh PatelDepartment of Medicine, Harvard Medical School, Boston, MA, USA; Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Mass General Brigham Heart and Vascular Institute, Massachusetts General Hospital, Boston, MA, USA.
Genevieve WojcikDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Laura RaffieldDepartment of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
David V ContiDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, CA, USA; Department of Biostatistics and Informatics, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Funding

Polygenic Risk Score Methods Development Consortium Coordinating CenterU01HG011697 · NHGRI · UNIVERSITY OF WASHINGTON · PI Kenneth M. Rice · 2021 to 2026
$8.8M
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Multiple AncestriesU01HG011723 · NHGRI · BROAD INSTITUTE, INC. · PI Alisa Knodle Manning, Josep Maria Mercader · 2021 to 2026
$5.7M
Enabling improved applicability and transferability of polygenic scores across populationsU01HG011719 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI Alicia Martin · 2021 to 2026
$5.5M
Polygenic risk scores for cardiometabolic disorders: the role of blood cells immune response and evolutionary adaptationU01HG011720 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yun Li, ALEXANDER P REINER · 2021 to 2026
$5.4M
PRS Center for Admixed Populations (CAPE)U01HG011715 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Eimear Elizabeth Kenny, Leslie A Lange · 2021 to 2026
$5.2M
Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk ScoresU01CA261339 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fei Chen, David V Conti · 2021 to 2026
$5.2M
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry - Study SitesU01HG011717 · NHGRI · UNIVERSITY OF MARYLAND BALTIMORE · PI ADEBAMOWO, SALLY NNEOMA, TAYO, BAMIDELE OLUSEGUN · 2021 to 2025
$4.6M
Polygenic Risk of Disease in Populations of Diverse AncestryU01HG011710 · NHGRI · MAYO CLINIC ROCHESTER · PI SCHAID, DANIEL J. · 2021 to 2025
$3.2M
Exposure to Per- and Polyfluoroalkyl Substances and Prostate Cancer: Opportunities for Prevention and Early DetectionK01ES035734 · NIEHS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Hari S Iyer · 2024 to 2026
$555k
NCI NIH HHS U01 CA261339NHGRI NIH HHS U01 HG011697NHGRI NIH HHS U01 HG011710NHGRI NIH HHS U01 HG011715NHGRI NIH HHS U01 HG011717NHGRI NIH HHS U01 HG011719NHGRI NIH HHS U01 HG011720NHGRI NIH HHS U01 HG011723NIEHS NIH HHS K01 ES035734
6 · The paper itself

Abstract

There is a growing interest in evaluating the intersection of genetic and environmental factors, particularly social determinants of health (SDoH). As both the distributions and associations of genetic and SDoH-related risk vary across populations, a thorough understanding of the interplay of these factors (genetics and SDoH across populations) is necessary for the appropriate design and interpretation of studies examining their combined impact on health outcomes. In this review, we review population descriptors, including self-reported social constructs and genetically defined constructs, highlighting the different concepts they may capture and when it may be appropriate to use them. We discuss the challenges of applying polygenic risk scores (PRSs) to populations distinct in their genetic architecture or social context from the cohort in which they were developed. We provide an overview of conceptual SDoH frameworks and measures at the individual and area levels, discussing how these measures are defined, assessed, utilized, and interpreted in health research. For evaluating SDoH and PRS jointly, we outline analytic considerations, including calculating main-effect estimates, conducting gene-environment interaction studies, testing for mediation, and incorporating these factors into clinical prediction algorithms. When examining across populations, we highlight opportunities and challenges of data harmonization across existing cohorts and biobanks and ethical considerations necessary before embarking on or reporting work in this field. In all cases, we highlight the criticality of basing scientific questions upon well-considered conceptual frameworks arising from prior established relationships between risk factors and disease.

Indexed as

Multifactorial InheritanceSocial Determinants of HealthGene-Environment InteractionGenetic Predisposition to DiseaseGenetic Risk ScoreGenome-Wide Association StudyHumansRisk Factorsgenetic ancestrygenetic similaritypolygenic riskpopulation descriptorsrace and ethnicityresearch ethicssocial determinants of health

Identifiers

PMID41785862
PMCPMC12981347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.